Strategic Collaborations MEDSIR operates as a bridge between oncology investigators and funding parties (Pharma, biotech, public institutions), indicating strong sales opportunities in partnership development, research funding alignment, and joint clinical trial programs.

Clinical Trial Network With an international network and a track record of supporting over 200 trial ideas across innovative drugs, there is potential to upsell expanded trial design services, investigator management, and accelerated study conception to publication workflows.

Recent Excellence Recent high-profile study results and collaborations (for example with Roche) showcased at major congresses signal credibility and a track record of delivering value, which can be leveraged to pursue tier-one pharma and larger biotech partnerships.

Growth Channels Active participation in key oncology forums and upcoming adoption of AI-powered predictive tools via partnerships suggests opportunities to cross-sell advanced analytics, study optimization platforms, and AI-driven patient-stratification services.

Tech & Compliance Adoption of Looker, cloud platforms, and GDPR compliance indicates reliability and modern infrastructure, enabling conversations around data governance, real-world evidence studies, and compliant multi-region trials for global sponsors.